IndiaTickerLatest filing: Updates - Emcure Pharmaceuticals Limited
ObservedCompany dossier
Emcure Pharmaceuticals
NSE:EMCURE · ISIN INE168P01015
- Close
- ₹1,903.7 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Emcure Pharmaceuticals
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹1,962.6 Cr · PAT ₹156.1 Cr.
Exchange XBRLLatest ownership: promoter group 77.83% and public 22.17% as of 30 Jun 2026.
Exchange XBRLLatest rating action: Emcure Pharmaceuticals Limited
Archived reportMaterial events
Open timeline →What changed recently
Observed
Source filing Updates - Emcure Pharmaceuticals Limited
NSE · exchange filing
Observed
Source filing Emcure Pharmaceuticals Ltd - 544210 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Update On Completion Of Acquisition Of Shares Of Gennova Biopharmaceuticals Limited.
BSE · exchange filing
Observed
Source filing Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Change in Management
BSE · exchange filing
Observed
Source filing Change in Director(s) - Emcure Pharmaceuticals Limited
NSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹1,962.6 Cr
- Profit after tax
- ₹156.1 Cr
- EPS
- ₹8.12
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 77.83%
- Public
- 22.17%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL